SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 44 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,987 | -30.4% | 57,309 | +5.7% | 0.00% | – |
Q2 2023 | $61,799 | +58756.2% | 54,210 | -22.8% | 0.00% | – |
Q1 2023 | $105 | +5.0% | 70,191 | +4.4% | 0.00% | – |
Q4 2022 | $100 | -99.9% | 67,242 | -15.0% | 0.00% | – |
Q3 2022 | $123,000 | -59.5% | 79,081 | -40.9% | 0.00% | – |
Q2 2022 | $304,000 | +164.3% | 133,705 | +168.8% | 0.00% | – |
Q1 2022 | $115,000 | -77.3% | 49,744 | -43.0% | 0.00% | – |
Q4 2021 | $506,000 | -81.4% | 87,290 | -66.3% | 0.00% | -100.0% |
Q3 2021 | $2,721,000 | – | 258,659 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Duquesne Family Office | 100,000 | $231,000 | 0.01% |
FNY Investment Advisers, LLC | 3,500 | $8,000 | 0.01% |
LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $88,000 | 0.00% |
UBS Group AG | 13,618 | $31,000 | 0.00% |
RHUMBLINE ADVISERS | 16,169 | $37,000 | 0.00% |
Ellevest, Inc. | 19 | $0 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 62,184 | $144,000 | 0.00% |
FMR LLC | 179 | $0 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 10,375 | $24,000 | 0.00% |